BeiGene
BGNE
#973
Rank
โ‚น1.729 T
Marketcap
โ‚น15,809
Share price
0.49%
Change (1 day)
22.29%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Market capitalization of BeiGene (BGNE)

Market cap: โ‚น1.729 Trillion

As of March 2025 BeiGene has a market cap of โ‚น1.729 Trillion. This makes BeiGene the world's 973th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BeiGene from 2016 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น1.729 T1.9%
2024โ‚น1.697 T2.89%
2023โ‚น1.649 T-15.02%
2022โ‚น1.941 T-5.11%
2021โ‚น2.046 T16.42%
2020โ‚น1.757 T139.54%
2019โ‚น733.69 B25.89%
2018โ‚น582.79 B105.09%
2017โ‚น284.17 B247.13%
2016โ‚น81.86 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
โ‚น1.78 B-99.90%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น100.01 B-94.22%๐Ÿ‡บ๐Ÿ‡ธ USA